Vol 5 (March 30, 2022): Digestive Medicine Research

Review Article 
Neuraxial anaesthesia and its role in enhanced recovery after surgery: a narrative review
Rita Agarwala, Ben Morrison
Digestive Medicine Research  
2022;
5:
20  
Review Article 
Advances in therapeutics for peritoneal metastases from colorectal cancer: a narrative review
Mason A. Vierra, Ryan B. Morgan, Oliver S. Eng
Digestive Medicine Research  
2022;
5:
18  
Review Article 
Adjuncts and multimodal analgesia: a narrative review
Victoria A. Bennett, Ben Morrison
Digestive Medicine Research  
2022;
5:
17  
Review Article 
Narrative review of gut microbiota and liver diseases: facts and fictions
Francisco Javier Valentin-Cortez, Jacqueline Córdova-Gallardo, Nahum Méndez-Sánchez
Digestive Medicine Research  
2022;
5:
16  
Review Article 
Narrative review on alcoholic liver disease: from fibrosis to cancer
Helmut K. Seitz, Manuela Neuman
Digestive Medicine Research  
2022;
5:
15  
Review Article 
Narrative review of bovine milk exosomes as a potential therapeutic option for hepatic fibrosis
Bodo C. Melnik, Ralf Weiskirchen, Wolfgang Stremmel, Swen Malte John, Gerd Schmitz
Digestive Medicine Research  
2022;
5:
14  
Review Article 
How do we assess analgesia efficacy?—a narrative review
Natasha Parrott, Leigh Kelliher
Digestive Medicine Research  
2022;
5:
12  
Original Article 
Minimally-invasive approach to synchronous colorectal cancer liver metastases: outcomes from a single centre
Jing Yu Ng, Chien-Chih Chen, Tzu-Jung Tsai
Digestive Medicine Research  
2022;
5:
10  
Editorial Commentary 
UGT1A1*6 genotype in Asian population and hard endpoint for locally advanced rectal cancer
Satoru Iwasa, Kei Muro, Junichi Sakamoto
Digestive Medicine Research  
2022;
5:
8  
Editorial Commentary 
The evolving landscape of BRAF inhibitors in BRAF mutant colorectal cancer and the added value of cytotoxic chemotherapy
Barbara Geerinckx, Annabel Smith, Timothy Price
Digestive Medicine Research  
2022;
5:
7  
Editorial Commentary 
Apatinib in an evolving landscape of antiangiogenics and immune checkpoint inhibitors in advanced hepatocellular carcinoma
Thanh Nga Thi Doan, Vi K. Chiu, Ju Dong Yang, Daneng Li, Andrew Hendifar, Arsen Osipov, Jeremy Lorber, Alexandra Gangi, Allan Silberman, May Cho, Jun Gong
Digestive Medicine Research  
2022;
5:
6  
Editorial Commentary 
Combined targeted therapy for BRAF mutant metastatic colorectal cancer: are we there yet?
Robin M. J. M. van Geel, Liselot B. J. Valkenburg-van Iersel
Digestive Medicine Research  
2022;
5:
5  
Editorial Commentary 
Optimal neoadjuvant chemotherapy for resectable advanced gastric cancer
Eisuke Booka, Hiroya Takeuchi
Digestive Medicine Research  
2022;
5:
4  
Editorial Commentary 
A BEACON of hope for BRAF-mutant metastatic colorectal cancer
Jennifer Mooi, Belinda Lee
Digestive Medicine Research  
2022;
5:
3  
Editorial Commentary 
Perioperative adjuvant, RESOLVE, toward new standards for locally advanced gastric cancer
Akira Tsuburaya
Digestive Medicine Research  
2022;
5:
2  
Editorial Commentary 
COREAN trial: long-term clinical impact of laparoscopic surgery in patients undergoing total mesorectal excision
Paula Domínguez-Garijo, F. Borja de Lacy, Antonio M. Lacy
Digestive Medicine Research  
2022;
5:
1